Oxycodone Tablets(Er) Suppliers & Bulk Manufacturers
Available Forms: Extended-Release Tablets
Available Strengths: 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Reference Brands: OxyContin, Roxicodone, Oxymorphone(US); OxyContin, OxyNorm(EU)
Category:
Analgesic
Oxycodone ER tablets activate mu-opioid receptors in the brain and spinal cord, blocking pain signals and altering pain perception. Benefits include sustained, long-lasting pain relief, improved patient comfort, and reduced dosing frequency. It effectively manages severe, persistent pain when used responsibly under medical supervision.
Oxycodone tablets(ER) is available in Extended-Release Tablets
and strengths such as 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Oxycodone tablets(ER) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Oxycodone tablets(ER) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Oxycodone ER (Extended-Release) tablets are approved in the US and EU for managing severe pain requiring long-lasting relief. In the US, brands like OxyContin are regulated by the FDA under strict control measures, supported by extensive clinical data and rigorous pharmacovigilance. In the EU, approval by the EMA involves detailed dossiers demonstrating safety, efficacy, and manufacturing quality, with strict regulations on prescribing and misuse prevention. Both regions enforce comprehensive licensing, risk management, and monitoring to mitigate abuse potential. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access, ensuring adherence to European and American standards for safe, effective opioid therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing